It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little context about the business behind these new medications.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Life Is Like a Game of Poker
Matters of the Heart
The Body That Got Me Through
That's What Friends Are For
The Change We Need
Introducing Chasing Life
It's Not Goodbye
Dr. Fauci's Long Year
Vaccines Behind Bars
India in Crisis
When Truth is Stranger Than Fiction
Tyler Perry’s Pandemic Response
What on Earth Happens Next?
An Immunologist Challenges the Status Quo
An American Success Story
I Got Vaccinated, But My Family Can’t
The Race Between Variants and Vaccines
Brazil's Covid Crisis
Hitting Pause on the J&J Vaccine
Vaccine Passports
Create your
podcast in
minutes
It is Free
Newscast
Consider This from NPR
What’s That Rash?
The Coronavirus Podcast
Coronavirus Central